🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Randomized, open label, multicentre phase II trial followed by phase III co...
Status
Completed
Location
CRLC Val d'Aurelle
Start Date
2004-04
Trial ID
NCT00208260
Treatments Being Tested
This Phase III, multicenter, randomized, open-label, controlled study is de...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2026-07
Trial ID
NCT07595913
Treatments Being Tested
This is a Phase 1/1b open-label study evaluating the safety, pharmacokineti...
Status
Completed
Location
HonorHealth Research Institute - Pima /ID# 105677
Start Date
2013-08-08
Trial ID
NCT01946074
Treatments Being Tested
To observe and evaluate the efficacy and safety of FOLFOX/FOLFIRI± target-d...
Status
Unknown
Location
Liaoning Cancer Hospital & Institute
Start Date
2022-08-01
Trial ID
NCT05797883
Treatments Being Tested
This is an open-label Phase 1a/b dose-escalation study to assess the safety...
Status
Completed
Location
UCSF
Start Date
2015-07-16
Trial ID
NCT02482441
Treatments Being Tested
The primary objective of the study is to determine the maximum tolerated do...
Status
Completed
Location
Alabama Oncology
Start Date
2013-03-29
Trial ID
NCT01803282
TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion cl...
Status
Recruiting
Location
Arizona Oncology Associates
Start Date
2020-07-14
Trial ID
NCT04485013
Open label Phase II study of FOLFIRI + Panitumumab using ultra-selection te...
Status
Completed
Location
Spanish Cooperative Group for Digestive Tumour Therapy
Start Date
2012-10
Trial ID
NCT01704703
Treatments Being Tested
This clinical trial will compare the efficacy and safety of the combination...
Status
Completed
Location
Multiple Locations
Start Date
2008-11
Trial ID
NCT00752570
Treatments Being Tested
PURPOSE: This randomized phase III trial is studying cetuximab and/or bevac...
Status
Completed
Location
Providence Cancer Center at Providence Hospital
Start Date
2005-11
Trial ID
NCT00265850
Treatments Being Tested